States must clampdown on hoarders: Centre to SC
States must clampdown on hoarders: Centre to SC
Last Updated: Mon, May 10th, 2021, 15:43:25hrs
New Delhi: All states must ensure special teams at different levels to mercilessly clamp down on hoarding and black marketing of drugs during the COVID-19 pandemic and send a clear message that trading in human miseries shall not be tolerated, the Centre has told the Supreme Court.
In an affidavit filed in the apex court, the Centre has said the Drugs Controller General of India (DCGI) had communicated to all state drugs controllers (SDCs) that there should be zero tolerance to any kind of hoarding or black marketing of drugs and also to instruct their enforcement staff to keep strict vigil and take stringent action.
Last Updated:
All About Roche s COVID Antibody Cocktail That India Approved As Treatment For Mild Cases
A Switzerland based drug maker, Roche has received approval from India s Central Drugs Standards Control Organisation (CDSCO) for COVID-19 emergency use .
Image: PTI
Widening the arsenal of drugs to combat COVID-19, a Switzerland-based drug maker, Roche has received approval from India s Central Drugs Standards Control Organisation (CDSCO) for use in emergency situations for treatment of COVID-19. The said experimental antibody cocktail was consumed by former US President Donald Trump when he contracted COVID-19 infection last year during his tenure at the White House.
The antibody cocktail is to be administered for the treatment of mild to moderate coronavirus disease in adults and pediatric patients (12 years of age or older, weighing at least 40 kg) who are confirmed to be infected with SARS-COV2 and who are at high risk of developing severe COVID-19 disease.
Private Companies Can Import Covid-19 Vaccines In India: What This Means indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Read more about Indices see positive start; breadth strong on Business Standard. Key benchmark indices are trading higher in early trade on buying demand in index pivotals. At 9:25 IST, the barometer index, the S&P BSE Sensex, was up 47.12 points or 0.1% at 48,724.67. The Nifty 50 index was up 28.30 points or 0.19% at
Cipla rose 1.10% to Rs 898.50 after the drug major said it will distribute Roche s antibody cocktail (Casirivimab and Imdevimab) in India.
Roche India said that the Central Drugs Standards Control Organisation (CDSCO) has provided an Emergency Use Authorisation (EUA) for Roche s antibody cocktail (Casirivimab and Imdevimab) in India. The approval was based on the data that have been filed for the EUA in the United States, and the scientific opinion of the Committee for Medicinal Products for Human Use (CHMP) in the European Union.
The antibody cocktail is to be administered for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age or older, weighing at least 40 kg) who are confirmed to be infected with SARS-COV2 and who are at high risk of developing severe COVID-19 disease.